02269.HK
WuXi Biologics (Cayman) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 50.35
+0.50%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 29.03x
- P/E 2027E
- 23.38x
- P/E 2028E
- 19.03x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 35.59x
- PEG TTM
- 1.62x
- Price / book
- 3.61x
- Price / sales
- 7.34x
- Price / cash flow
- 37.71x
Enterprise value
- Enterprise value
- HKD 198.3B
- EV / sales
- 7.18x
- EV / EBITDA
- 19.18x
- EV / EBIT
- 22.18x
- Market cap
- HKD 202.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026